why choose us

First received: September 21, 2022

Clinical Trial: 18F-Fluciclovine PET-MRI in High-grade Glioma

Study Status: Completed

Recruit Status: RECRUITING

Condition: Glioma

Study Type: INTERVENTIONAL


Official Title: Evaluation of 18F-Fluciclovine PET-MRI to Differentiate Tumor Progression From Post-treatment Changes in Pediatric High-grade Glioma (HGG)

Brief Summary: The purpose of this study is to see if 18F-fluciclovine (Axumin®) PET imaging is useful and safe in the management of children with High Grade Gliomas.Investigators seek to determine if this imaging will help doctors tell the difference between tumor growth (progression) and other tumor changes that can occur after treatment.

Read more